Prerequisites to implementing a pharmacogenomics program in a large health-care system

K. D. Levy, B. S. Decker, J. S. Carpenter, David A. Flockhart, P. R. Dexter, Z. Desta, T. C. Skaar

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on translating PGx research into clinical practice. We describe what have been found to be the key requirements that must be delivered in order to ensure a successful and enduring PGx implementation within a large health-care system.

Original languageEnglish (US)
Pages (from-to)307-309
Number of pages3
JournalClinical Pharmacology and Therapeutics
Volume96
Issue number3
DOIs
StatePublished - Sep 2014

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Prerequisites to implementing a pharmacogenomics program in a large health-care system'. Together they form a unique fingerprint.

  • Cite this